Litigation

Recent Posts

Supreme Court Won't Take Up Egregious Fraudulent Misjoinder In Hormone Cases
Posted on 12 Oct 2010 by Tom Moylan

WASHINGTON, D.C. - (Mealey's) The U.S. Supreme Court on Oct. 12 denied review of a circuit court ruling that 112 hormone replacement therapy (HRT) plaintiffs did not fraudulently misjoin nondiverse defendants in order to keep their cases in Minnesota... Read More

Tags: Solvay Pharmaceuticals Inc. , Wyeth , Judge William R. Wilson Jr. , Watson Laboratories Inc. , misjoinder , nondiverse defendants , HRT , personal injury , Wyeth v. Sandra Kirkland , Jurisdiction , Barr Laboratories Inc. , Novartis Pharmaceuticals Corp. , Litigation , Mead Johnson & Co. , multidistrict litigation , lawsuit , hormone replacement therapy , U.S. Supreme Court , Prempro , MDL , torts , In re: Prempro Products Liability Litigation

Jury Awards $1.3 Million In Zometa Jaw Injury Trial After Botching 1st Verdict Form
Posted on 23 Sep 2013 by Tom Moylan

ORLANDO, Fla. — (Mealey’s) A Florida federal jury on Sept. 20 found that Novartis Pharmaceuticals Corp. failed to warn a cancer patient about the risk of osteonecrosis of the jaw (ONJ) and awarded her $1.3 million in medical expenses and non... Read More

Tags: drugs , Nancy Guenther , Damages , osteonecrosis of the jaw , et al. v. Novartis Pharmaceutical Corporation , Florida , ONJ , Novartis Pharmaceuticals Corp. , Litigation , Zometa , verdict

Jury Awards Plaintiff $285,000 In 5th Fosamax MDL Trial But Finds No Design Defect
Posted on 5 Feb 2013 by Tom Moylan

NEW YORK - (Mealey's) A New York federal jury on Feb. 5 ordered Novartis Pharmaceuticals Corp. to pay $285,000 to a plaintiff for allegedly failing to warn her or her doctor that Fosamax carries a risk of osteonecrosis of the jaw (ONJ) ( In Re: Fosamax... Read More

Tags: pharmaceutical litigation , osteonecrosis of the jaw , Rhoda E. Scheinberg v. Merck & Co. , ONJ , Merck , Novartis Pharmaceuticals Corp. , Litigation , multidistrict litigation , Rhonda E. Scheinberg , Fosamax , In Re: Fosamax Products Liability Litigation , Wyeth v. Levine

California High Court: Pharmacies That 'Passed On' Higher Costs Have UCL Injury
Posted on 12 Jul 2010 by Bryan Redding

SAN FRANCISCO - (Mealey's) Pharmacies have standing to pursue unfair competition law (UCL) claims alleging that they paid higher prices because of price fixing by pharmaceutical companies, even though they passed the higher prices on to consumers... Read More

Tags: pharmacies , Eli Lilly & Co. , Hanover Shoe v. United Shoe Mach , Johnson & Johnson Health Care Systems Inc. , Boehringer Ingelheim Pharmaceuticals , pharmaceutical companies , Pharmaceutical Research and Manufacturers of America , James Clayworth , Abbott Laboratories , Pfizer Inc. , Wyeth Pharmaceuticals , California , UCL , Amgen Inc. , Allergan Inc. , Illinois Brick Co. v. Illinois , Business and Professions Code , price fixing , Cartwright Act , unfair competition law , AstraZeneca International , California Supreme Court , Novartis Pharmaceuticals Corp. , Hoffman-LaRoche Inc. , Litigation , lawsuit , Merck & Co. , Bristol-Myers Squibb Co.